Blackstone Inc. (BX)
After hours: 07:59PM EDT
| Previous Close | 122.03 |
| Open | 123.81 |
| Bid | 122.50 x 1200 |
| Ask | 123.00 x 800 |
| Day's Range | 121.42 - 126.35 |
| 52 Week Range | 49.40 - 136.89 |
| Volume | 2,816,089 |
| Avg. Volume | 3,551,009 |
| Market Cap | 87.482B |
| Beta (5Y Monthly) | 1.34 |
| PE Ratio (TTM) | 22.49 |
| EPS (TTM) | 5.47 |
| Earnings Date | Oct. 26, 2021 - Nov. 01, 2021 |
| Forward Dividend & Yield | 3.02 (2.67%) |
| Ex-Dividend Date | Jul. 30, 2021 |
| 1y Target Est | 116.68 |
- Zacks
Blackstone Inc. (BX) Outpaces Stock Market Gains: What You Should Know
Blackstone Inc. (BX) closed the most recent trading day at $123.03, moving +0.82% from the previous trading session.
- Business Wire
Blackstone Announces Appointment of Emily Yoder as Senior Managing Director, Strategic Relationships
NEW YORK, October 13, 2021--Blackstone today announced the appointment of Emily Yoder as Senior Managing Director, Strategic Relationship Management. She will serve as a primary interface with Blackstone’s banking and other financial services partners. In this newly created role, Ms. Yoder will be responsible for delivering a firm-wide approach to relationship management.
- Business Wire
Monika Vnuk and Matt Lane join Blackstone Life Sciences as Managing Directors
CAMBRIDGE, Mass., October 13, 2021--Blackstone Life Sciences ("BXLS"), Blackstone’s life sciences business, announced today that Dr. Monika Vnuk and Matt Lane have joined BXLS as Managing Directors in the firm’s Cambridge office. Dr. Vnuk joins from Pfizer, where she served as Vice President of Worldwide Business Development, having recently led Pfizer’s partnership with BioNTech for their COVID-19 vaccine. Mr. Lane joins with more than 20 years of experience in advising life sciences companies,
